53 related articles for article (PubMed ID: 14550926)
1. Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent.
Schwarz A; Krätke O; Burwinkel M; Riemer C; Schultz J; Henklein P; Bamme T; Baier M
Neurosci Lett; 2003 Oct; 350(3):187-9. PubMed ID: 14550926
[TBL] [Abstract][Full Text] [Related]
2. Immunization with Genetically Modified Trypanosomes Provides Protection against Transmissible Spongiform Encephalopathies.
Triller G; Garyfallos DA; Papavasiliou FN; Sklaviadis T; Stavropoulos P; Xanthopoulos K
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142526
[TBL] [Abstract][Full Text] [Related]
3. Treatment of microglia with Anti-PrP monoclonal antibodies induces neuronal apoptosis
Adhikari UK; Sakiz E; Habiba U; Mikhael M; Senesi M; David MA; Guillemin GJ; Ooi L; Karl T; Collins S; Tayebi M
Heliyon; 2021 Dec; 7(12):e08644. PubMed ID: 35005289
[TBL] [Abstract][Full Text] [Related]
4. Epitope-specific anti-PrP antibody toxicity: a comparative
Adhikari UK; Tayebi M
Prion; 2021 Dec; 15(1):155-176. PubMed ID: 34632945
[TBL] [Abstract][Full Text] [Related]
5. Cross-Linking Cellular Prion Protein Induces Neuronal Type 2-Like Hypersensitivity.
Adhikari UK; Sakiz E; Zhou X; Habiba U; Kumar S; Mikhael M; Senesi M; Guang Li C; Guillemin GJ; Ooi L; David MA; Collins S; Karl T; Tayebi M
Front Immunol; 2021; 12():639008. PubMed ID: 34394070
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with Prion Peptide-Displaying Polyomavirus-Like Particles Prolongs Incubation Time in Scrapie-Infected Mice.
Eiden M; Gedvilaite A; Leidel F; Ulrich RG; Groschup MH
Viruses; 2021 Apr; 13(5):. PubMed ID: 33946367
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy against Prion Disease.
Ma Y; Ma J
Pathogens; 2020 Mar; 9(3):. PubMed ID: 32183309
[TBL] [Abstract][Full Text] [Related]
8. Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson's Disease.
Shen N; Song G; Yang H; Lin X; Brown B; Hong Y; Cai J; Cao C
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083520
[TBL] [Abstract][Full Text] [Related]
9. Recombinant prion protein vaccination of transgenic elk PrP mice and reindeer overcomes self-tolerance and protects mice against chronic wasting disease.
Abdelaziz DH; Thapa S; Brandon J; Maybee J; Vankuppeveld L; McCorkell R; Schätzl HM
J Biol Chem; 2018 Dec; 293(51):19812-19822. PubMed ID: 30397182
[TBL] [Abstract][Full Text] [Related]
10. Induction of PrP
Taschuk R; Scruten E; Woodbury M; Cashman N; Potter A; Griebel P; Tikoo SK; Napper S
Prion; 2017 Sep; 11(5):368-380. PubMed ID: 28968152
[TBL] [Abstract][Full Text] [Related]
11. In vitro neutralization of prions with PrP(Sc)-specific antibodies.
Taschuk R; Van der Merwe J; Marciniuk K; Potter A; Cashman N; Griebel P; Napper S
Prion; 2015; 9(4):292-303. PubMed ID: 26284508
[TBL] [Abstract][Full Text] [Related]
12. Safety, specificity and immunogenicity of a PrP(Sc)-specific prion vaccine based on the YYR disease specific epitope.
Taschuk R; Marciniuk K; Määttänen P; Madampage C; Hedlin P; Potter A; Lee J; Cashman NR; Griebel PJ; Napper S
Prion; 2014; 8(1):51-9. PubMed ID: 24509522
[TBL] [Abstract][Full Text] [Related]
13. The immunobiology of prion diseases.
Aguzzi A; Nuvolone M; Zhu C
Nat Rev Immunol; 2013 Dec; 13(12):888-902. PubMed ID: 24189576
[TBL] [Abstract][Full Text] [Related]
14. Detection and control of prion diseases in food animals.
Hedlin P; Taschuk R; Potter A; Griebel P; Napper S
ISRN Vet Sci; 2012; 2012():254739. PubMed ID: 23738120
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in prion disease.
Roettger Y; Du Y; Bacher M; Zerr I; Dodel R; Bach JP
Nat Rev Neurol; 2013 Feb; 9(2):98-105. PubMed ID: 23247613
[TBL] [Abstract][Full Text] [Related]
16. Could immunomodulation be used to prevent prion diseases?
Wisniewski T; Goñi F
Expert Rev Anti Infect Ther; 2012 Mar; 10(3):307-17. PubMed ID: 22397565
[TBL] [Abstract][Full Text] [Related]
17. Th2-polarised PrP-specific transgenic T-cells confer partial protection against murine scrapie.
Iken S; Bachy V; Gourdain P; Lim A; Grégoire S; Chaigneau T; Aucouturier P; Carnaud C
PLoS Pathog; 2011 Sep; 7(9):e1002216. PubMed ID: 21909267
[TBL] [Abstract][Full Text] [Related]
18. A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines.
Jones DR; Taylor WA; Bate C; David M; Tayebi M
PLoS One; 2010 Mar; 5(3):e9804. PubMed ID: 20339552
[TBL] [Abstract][Full Text] [Related]
19. Anti-idiotypic antibodies: a new approach in prion research.
Colja Venturini A; Bresjanac M; Vranac T; Koren S; Narat M; Popović M; Curin Serbec V
BMC Immunol; 2009 Mar; 10():16. PubMed ID: 19298674
[TBL] [Abstract][Full Text] [Related]
20. Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.
Song CH; Honmou O; Ohsawa N; Nakamura K; Hamada H; Furuoka H; Hasebe R; Horiuchi M
J Virol; 2009 Jun; 83(11):5918-27. PubMed ID: 19297502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
